COMMUNIQUÉS West-GlobeNewswire

BioTelemetry, Inc. Completes Acquisition of Geneva Healthcare, Inc.

04/03/2019 - 14:30

MALVERN, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost [...]

Eyenovia to Participate in Two Upcoming Investor Conferences

04/03/2019 - 14:30

NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]

PhaseBio Appoints Richard A. van den Broek to Board of Directors

04/03/2019 - 14:30

MALVERN, Pa., and SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]

SELLAS Life Sciences Announces Presentation of Final Data Analysis from Phase 2b Study of Nelipepimut-S Plus Trastuzumab at the 2019 ASCO-SITC Clinical Immuno-Oncology Meeting

04/03/2019 - 14:30

NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]

Assure Holdings Announces Settlement with Former President and Director

04/03/2019 - 14:30

DENVER, March 04, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has entered into a settlement and mutual [...]

Albireo to Present at Cowen and Company 39th Annual Health Care Conference

04/03/2019 - 14:30

BOSTON, March 04, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]

Advantis Corp. Prepares for OTCBB

04/03/2019 - 14:30

NEWPORT BEACH, CA, March 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it is preparing for the audit necessary for their OTCBB up-listing. Advantis is [...]

ITC Institutes Section 337 Investigation Based on Align Technology Claims of Scanner Related 3Shape Patent Infringement

04/03/2019 - 14:30

SAN JOSE, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today that on February 27, 2019 the United States International Trade Commission (ITC) voted to institute a third [...]

10th Consecutive Quarter With Increased Revenue

04/03/2019 - 14:30

VANCOUVER, British Columbia, March 04, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”) announces more than $1.4M in sales in its second quarter, compared to $1.0M in the first [...]

Arbutus to Present at Cowen Health Care Conference

04/03/2019 - 14:30

WARMINSTER, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Mark Murray, Arbutus [...]

North Bud Farms Upgrades to OTCQB to Engage and Expand U.S. Investor Audience

04/03/2019 - 14:30

TORONTO, March 04, 2019 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) ("NORTHBUD" or the "Company") today announced that effective today, shares of the Company have been approved for and will [...]

Daxor Corporation Announces Rise in Kit Sales and Files Form N-CSR For 2018

04/03/2019 - 14:30

NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today filed a [...]

ChemoCentryx to Hold Fourth Quarter 2018 Financial Results Conference Call on Monday, March 11, 2019

04/03/2019 - 14:30

MOUNTAIN VIEW, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's fourth quarter 2018 financial results will be released after market close on Monday, March [...]

Vericel to Present at Multiple Upcoming Investor Conferences

04/03/2019 - 14:30

CAMBRIDGE, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced presentations at multiple [...]

Evoke Pharma Receives Preliminary FDA Communication on Gimoti™ NDA

04/03/2019 - 14:30

SOLANA BEACH Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), today announced the receipt of a multi-disciplinary review (DR) letter from the U.S. Food and Drug Administration (FDA) in [...]

MedTainer Announces Re-Positioning; Level of Industry Interest Increases

04/03/2019 - 14:30

CORONA, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced that the company has begun to re-position in order to attract new and diverse levels of investment and investors. This move [...]

Vystar Receives Second European Patent for Reduced Allergenicity Natural Rubber Latex

04/03/2019 - 14:23

Vystar’s Vytex® deproteinization method reduces allergenicity and odor, Manufacturing process uses less water, chemical and dyes for naturally, purer, whiter and stronger latex WORCESTER, Mass., March 04, 2019 (GLOBE [...]

Novo Nordisk A/S - Share repurchase programme

04/03/2019 - 14:10

Bagsværd, Denmark, 4 March 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Microbot Medical Announces Notice of Intention to Grant of European Patent for Adjustable Guidewire Technology

04/03/2019 - 14:07

HINGHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Further expanding its global IP portfolio, Microbot Medical Inc. (Nasdaq CM: MBOT) received an official communication from the European Patent Office regarding its [...]